Correspondence 0001213900-25-011749 from Onconetix, Inc. (ONCO)

Onconetix, Inc.
Date: Feb. 10, 2025 · CIK: 0001782107 · Accession: 0001213900-25-011749

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-284507

Date

February 10, 2025

Author

/s/ Karina Fedasz

Form

CORRESP

Company

Onconetix, Inc.

Letter

Onconetix, Inc.

201 E. Fifth Street, Suite 1900

Cincinnati, OH 45202

VIA EDGAR

February 10, 2025

U.S. Securities and Exchange Commission

Office of Life Sciences

Washington, D.C. 20549

Attn: Jessica Dickerson

Re:

Onconetix, Inc.

Registration Statement on Form S-1

Filed January 27, 2025

File No. 333-284507

Ladies and Gentleman,

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. EST on Tuesday, February 11, 2025, or as soon as thereafter practicable.

Very truly yours,
/s/ Karina Fedasz

Show Raw Text

CORRESP
1
filename1.htm

Onconetix, Inc.

201 E. Fifth Street, Suite 1900

Cincinnati, OH 45202

VIA EDGAR

February 10, 2025

U.S. Securities and Exchange Commission

Office of Life Sciences

Washington, D.C. 20549

Attn: Jessica Dickerson

    Re:

    Onconetix, Inc.

    Registration Statement on Form S-1

    Filed January 27, 2025

    File No. 333-284507

Ladies and Gentleman,

Pursuant to Rule 461 under the
Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration
Statement so that it will become effective at 5:00 p.m. EST on Tuesday, February 11, 2025, or as soon as thereafter practicable.

    Very truly yours,

    /s/ Karina Fedasz

    By: Karina Fedasz

    Title: Interim Chief Financial Officer

    cc:

    Ellenoff Grossman & Schole LLP

SecProbe.io